These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29344766)

  • 41. Assessment of the effect of palliative radiotherapy for cancer patients with intracranial metastases using EORTC-QOL-C30 questionnaire.
    Yaneva MP; Semerdjieva MA
    Folia Med (Plovdiv); 2006; 48(2):23-9. PubMed ID: 17408073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.
    Ozdemir Y; Yildirim BA; Topkan E
    J Neurooncol; 2016 Sep; 129(2):329-35. PubMed ID: 27306442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
    Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
    J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Palliative radiotherapy: New prognostic factors for patients with bone metastasis.
    Steinvoort-Draat IN; Otto-Vollaard L; Quint S; Tims JL; de Pree IMN; Nuyttens JJ
    Cancer Radiother; 2024 Jun; 28(3):236-241. PubMed ID: 38871605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
    Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
    Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
    PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
    Steinmann D; Paelecke-Habermann Y; Geinitz H; Aschoff R; Bayerl A; Bölling T; Bosch E; Bruns F; Eichenseder-Seiss U; Gerstein J; Gharbi N; Hagg J; Hipp M; Kleff I; Müller A; Schäfer C; Schleicher U; Sehlen S; Theodorou M; Wypior HJ; Zehentmayr F; van Oorschot B; Vordermark D
    BMC Cancer; 2012 Jul; 12():283. PubMed ID: 22780988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive factors for well-being in advanced cancer patients referred for palliative radiotherapy.
    Lien K; Zeng L; Zhang L; Nguyen J; Di Giovanni J; Popovic M; Jamani R; Cramarossa G; Culleton S; Chow E
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):443-51. PubMed ID: 22794326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients.
    Yennurajalingam S; Kim YJ; Zhang Y; Park J; Arthur J; Chisholm GB; Williams JL; Bruera E
    Palliat Support Care; 2018 Feb; 16(1):23-31. PubMed ID: 28264748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical presentations of below knee bone metastases: a case series.
    Choi M; Probyn L; Rowbottom L; McDonald R; Bobrowski A; Chan S; Zaki P; Turner A; Chow E
    Ann Palliat Med; 2017 Aug; 6(Suppl 1):S85-S89. PubMed ID: 28249547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.
    Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
    Int J Circumpolar Health; 2017; 76(1):1270080. PubMed ID: 28452680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?
    Rades D; Huttenlocher S; Hornung D; Blanck O; Schild SE; Fischer D
    Radiat Oncol; 2014 Dec; 9():267. PubMed ID: 25472758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System.
    Zeng L; Koo K; Zhang L; Jon F; Dennis K; Holden L; Nguyen J; Tsao M; Barnes E; Danjoux C; Sahgal A; Chow E
    Support Care Cancer; 2012 May; 20(5):1037-42. PubMed ID: 21538097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.
    Pronzato P; Bruna F; Neri E; Roveri D; Trabucchi A; Vanoli M; Vigani A; Vaira F; Losardo P; Bertelli G
    Anticancer Res; 1995; 15(2):517-9. PubMed ID: 7539236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.